<?xml version="1.0" encoding="UTF-8"?>
<p>The role of anti-HBs screening before immunosuppressive therapy remains unclear, and the presence of anti-HBs does not imply prevention of HBV reactivation. However, anti-HBs testing may be helpful for detecting past infection in patients who are HBsAg-negative and anti-HBc-positive. Furthermore, loss of anti-HBs can predict HBV reactivation during surveillance [
 <xref rid="b48-ir-2019-09155" ref-type="bibr">48</xref>-
 <xref rid="b50-ir-2019-09155" ref-type="bibr">50</xref>].
</p>
